February 16, 2024
Health Law Weekly

Featured Articles

Final Substance Use Disorder Confidentiality Rule Released

  • Gerald E. DeLoss, Illinois Association for Behavioral Health

Medicare Advantage Enrollment Overtakes Traditional Medicare: Is There Concern with the Rising Instability of Payment Benchmarks?

  • Tyler Marshall, Berkeley Research Group
  • Nikki Doherty, BRG

Top Ten 2024: Reproductive Health Update

Hot Topics in Provider Repayments

Top Ten 2024: Reproductive Health Update

Current Topics

Fraud and Compliance

DME Supplier Agrees to $25.5 Million Settlement of Fraud Allegations

U.S. Court in California Allows Whistleblower Claim Against Kaiser Alleging Compliance Software Tampering

Telemedicine Company Owner Pleads Guilty in DME Kickback Scheme

Psychiatrist Convicted of Illegal Drug Importation Scheme

Testing Lab Co-owner Admits $3.8 Million Fraudulent Billing Scheme

Health Clinic Administrator Sentenced to Five Years in Prison for Medicaid Fraud

Dental Clinic Worker Found Guilty of Kickback Conspiracy

Government Reimbursement

Telehealth Claims During Pandemic Generally Met Medicare Requirements, OIG Finds

U.S. Court in Massachusetts Nixes Medicare Advantage Plan’s Lien on Wrongful Death Proceeds

U.S. Court in Texas Rejects Groups' Bid to Block Medicare Drug Price Negotiation Program

Proposed Rule Addresses Medicare Accrediting Organization Conflicts

CMS Issues Second Draft Guidance on New Medicare Part D Monthly Prescription Payment Plan

Health Care Finance and Transactions

Gilead Sciences to Expand Liver Disease Pipeline with Biotech CymaBay Therapeutics Buy

Labor and Employment

U.S. Court in Mississippi Refuses to Dismiss Physician’s Whistleblower Retaliation Claim Under EMTALA

Life Sciences

FTC, HHS Seek Feedback on GPOs, Drug Wholesalers' Potential Role in Generic Drug Shortages
Current Issue